Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:25 PM
Ignite Modification Date:
2025-12-24 @ 4:25 PM
NCT ID:
NCT05654766
Eligibility Criteria:
Inclusion Criteria:
* Pediatric participants with hemorrhagic syndrome (hemorrhagic rash, bruising, bleeding, increased bleeding of the skin and mucous membranes, spontaneous hemorrhages in soft tissues and joints)
* Pediatric participants with acute leukemia
* Parameters of the plasma level of blood coagulation correspond to the age normal levels
Exclusion Criteria:
* Anticoagulation drug therapy
* Antiaggregation drug therapy
* Biologically active additives
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
17 Years
Study:
NCT05654766
Study Brief:
Protocol Section:
NCT05654766